Adenomyosis

Obstetrics and Gynecology Clinics of North America

Volumn 30, Issue 1, 2003, Pages 63-82

  Matalliotakis, I M ^a,c   Kourtis, A I ^b   Panidis, D K ^b  

^a UNIVERSITY OF CRETE   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

5 ETHOXYMETHOXY N HYDROXY 2 METHYL 4 (4 PHENOXYBENZAMIDO)PENTANAMIDE; BROMOCRIPTINE; DANAZOL; GESTAGEN; GONADORELIN DERIVATIVE; GROWTH HORMONE; MATRIX METALLOPROTEINASE INHIBITOR; MIFEPRISTONE; PROGESTERONE; PROLACTIN; UNCLASSIFIED DRUG;

ADENOMYOSIS; CLINICAL FEATURE; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; DISEASE MODEL; DYSENTERY; DYSPAREUNIA; ELECTROCOAGULATION; ENDOMETRIUM ABLATION; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYSTERECTOMY; IMAGE ANALYSIS; INCIDENCE; INFERTILITY; MUSCLE BIOPSY; MYOMETRIUM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PELVIS PAIN SYNDROME; PREGNANCY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REVIEW; SYMPTOM; UTERUS BLEEDING;

ENDOMETRIOSIS; FEMALE; HUMANS; INFERTILITY, FEMALE; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 0037346944     PISSN: 08898545     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8545(02)00053-0     Document Type: Review

References (145)

1. Rokitansky K. Über uterusdruesen-neubildung. Z Gesellschaft Arzte Wien 1860;16:577-81.
2. Schatz F. Ein fall von fibroadenoma cysticum diffusum et poly-posum corporis et colli uteri. Arch Gynakol 1883;22:456-8.
3. Chiari H. Zur pathologischen anatomie des eileiter-catarrhs. Zeitschrift für Heilkunde 1887;8: 457-61.
4. Diesterweg A. Ein fall von cystofibroma uteri verum. Zeitschrify für Geburtsheilkunde und Gynakologie 1883;9:191-5.
5. Ruge C. Adenomyomata. Ztschr Deburtsch Gynak 1889;16:577-9.
6. th edition. 1892. p. 318.
7. Von Recklinghausen F. Die adenomyomata und cystadenomata der uterus und tubenwandung: ihre abkunft von resten des wolffischen koerpers. Berlin: August Hirschwald Verlag; 1896.
8. Meyer R. Ueber die genese der cystadenome und adenomyome des uterus, mit demonstrationene. Ztschr Geburtsh Gynakol 1897;37:327-35.
9. Meyer R. Über entzundliche heterotope epithelwucherungen im weiblichen genitalgebiete und über eine bis in die wurzel des mesocolon ausgedehnte benigne wurzel des darmepithels. Virchows Arch Pathol Anat 1909;155:487-92.
10. Cullen TS. Adenomyoma of the uterus. Philadelphia: W.B. Saunders Co.; 1908.
11. Taussig FS. A study of the lymph glands in cancer of the cervix and cancer of the vulva. Am J Obstet Gynecol 1938;36:819-22.
12. Marcus CC. Relationship of adenomyosis uteri to endometrial hyperplasia and endometrial carcinoma. Am J Obstet Gynecol 1961;82:408-16.
13. Guamaccia MM, Silverberg K, Olive D. Endometriosis and adenomyosis. In: Copeland LJ, Jarrel JF, editors. Textbook of gynecology. Philadelphia: W.B. Saunders Co.; 2000. p. 687-721.
14. Frankl O. Adenomyosis uteri. Am J Obstet Gynecol 1925;10:680-4.
15. Bird CC, McElin TW, Manalo-Esrella P. The elusive adenomyosis of the uterus. Am J Obstet Gynecol 1972;112:583-93.
16. Ferenczy A. Pathophysiology of adenomyosis. Hum Reprod 1998;4:312-22.
17. Hendrickson MR, Kempson RL. Non-neoplastic conditions of the myometrium and uterine serosa. In: Copeland LJ, Jarrel JF, editors. Surgical pathology of the uterine corpus. Philadelphia: W.B. Saunders Co.; 1980. p. 452-67.
18. Emge LA. Problems in the diagnosis of adenomyosis uteri. West J Surg 1956;64:291-305.
19. Israel SL, Woutersz TB. Adenomyosis: a neglected diagnosis. Obstet Gynecol 1959;14:168-73.
20. Counseller VS. Endometriosis: a clinical and surgical review. Am J Obstet Gynecol 1938; 36:877-86.
21. Lewinski H. Bietrag zur frage der adenomyosis. Zentralbl Gynakol 1931;55:2163-6.
22. Kismer RW. Principles and practice of gynecology. Chicago: Year Book Medical Publishers; 1964.
23. Owolabi TO, Strickler RC. Adenomyosis: a neglected diagnosis. Obstet Gynecol 1977;50: 424-8.
24. Vercellini P, Boxxiolone L, Vendola N. Peritoneal endometriosis: morphologic appearance in women with chronic pelvic pain. J Reprod Med 1991;36:533-6.
25. Vercillini P, Parazzini F, Oldani S. Adenomyosis at hysterectomy: a study on frequency distribution and patient characteristics. Hum Reprod 1995;10:1160-5.
26. Rao BN, Persaud V. Adenomyosis uteri. West Indian Med J 1982;31:205-8.
27. Vercellini P, Trespidi L, De Giorgi O, Cortesi I, Parazzini F, Crosignani PG. Endometriosis and pelvic pain: relation to disease stage and localization. Fertil Steril 1996;65:299-302.
28. Ridley JH. The histogenesis of endometriosis: a review of facts and fancies. Obstet Gynecol 1968;23:1-35.
29. Ferenczy A, Bergeron C. Histology of the human endometrium: from birth to senescence. Ann N Y Acad Sci 1991;622:6-27.
30. Ferenczy A. Regeneration of the human endometrium. In: Fenoglio CM, Wolff M, editors. Progress in surgical pathology. New York: Masson; 1980. p. 57-173.
31. Gaetje R, Kotzian S, Hermann G. Invasiveness of endometriotic cells in vitro. Lancet 1995; 346:1463-4.
32. Chiquet-Ehrismann R, Kalla P, Pearson CA. Participation of tenascin and TGF-beta in reciprocal epithelial-mesenchymal interactions of MCF7 cells and fibroblasts. Cancer Res 1989; 49:4322-5.
33. Vollmer G, Siegal GP, Chiquet-Ehrismann R. Tenascin expression in the human endometrium and in endometrial adenocarcinomas. Lab Invest 1990;62:725-30.
34. Lei M, Rao CV, Lincoln SR. Increased expression of human chorionic gonadotropin/human leuteinizing hormone receptors in adenomyosis. J Clin Endocrinol Metab 1993;76:763-8.
35. Lei ZM, Reshef E, Rao CV. The expression of human chorionic gonadotropin/luteinizing hormone receptors in human endometrial and myometrial blood vessels. J Clin Endocrinol Metab 1992;75:651-9.
36. Lin J, Lei ZM, Lojun S. Increased expression of luteinizing hormone/human chorionic gonadotrophin receptor gene in human endometrial carcinomas. J Clin Endocrinol Metab 1994; 79:1483-91.
37. Tamaya T, Motoyama T, Ohono Y. Steroid receptor levels and histology of endometriosis and adenomyosis. Fertil Steril 1979;31:396-400.
38. van der Walt LA, Sanfilippo JS, Siegel JE. Estrogen and progestin receptors in human uterus: reference ranges of clinical conditions. Clin Physiol Biochem 1986;4:217-28.
39. Yamamoto T, Noguchi T, Tamura T. Evidence for estrogen synthesis in adenomyotic tissue. Am J Obstet Gynecol 1993;169:734-8.
40. Takahashi K, Nagata H, Kitao M. Clinical usefulness of determination of estradiol level in the menstrual blood for patients with endometriosis. Acta Obstet Gynaecol Scand 1989;41: 1849-50.
41. Urabe M, Yamamoto T, Kitawaki J. Estrogen biosynthesis in human uterine adenomyosis. Acta Endocrinol (Copenh) 1989;121:259-64.
42. Parrot E, Butterworth M, Green A, White IN, Greaves P. Adenomyosis: a result of disordered stromal differentiation. Am J Pathol 2001;159:623-30.
43. Ota H, Igarashi S. Expression of major histocompatibility complex class II antigen in endometriotic tissue in patients with endometriosis and adenomyosis. Fertil Steril 1993;60:834-8.
44. Ota H, Igarashi S, Tanaka T. Expression of KLT cells and adhesion molecules in endometriotic tissue in patients with endometriosis and adenomyosis. Am J Reprod Immunol 1996; 35:477-82.
45. Bulmer JN, Jones RK, Searle RF. Intraepithelial leucocytes in endometriosis and adenomyosis: comparison of eutopic and ectopic endometrium with normal endometrium. Hum Reprod 1998; 13:2910-5.
46. Weed JC, Arquembourg PC. Endometriosis: can it produce an autoimmune response resulting in infertility? Clin Obstet Gynecol 1980;23:885-93.
47. Kreiner D, Fromowitz KB, Richardson DA. Endometrial immunofluorescence associated with endometriosis and pelvic inflammatory disease. Fertil Steril 1986;46:243-6.
48. Tabibzadeh S, Sun XZ, Kong QF. Induction of a polarized micro-environment by human T cells and interferon-gamma in three-dimensional pheroid cultures of human endometrial epithelial cells. Hum Reprod 1993;8:182-92.
49. Ferenczy A, Bertrand G, Gelfand MM. Proliferation kinetics of human endometrium during the normal menstrual cycle. Am J Obstet Gynecol 1979;133:859-67.
50. Ota H, Igarashi S, Hatazawa J, Tanaka T. Is adenomyosis an immune disease? Hum Reprod 1998;4:360-7.
51. Jeffcoate TNA, Potter AL. Endometriosis as a manifestation of ovarian dysfunction. J Obstet Gynecol 1934;41:684-707.
52. Ficicioglu C, Tekin HI, Arioglu PF. A murine model of adenomyosis: the effects of hyperprolactinemia induced by fluoxetine hydrochloride, a selective serotonin reuptake inhibitor, on adenomyosis induction in Wistar albino rats. Acta Eur Fertil 1995;26:75-9.
53. Mori T, Nagasawa H. Mechanisms of development of prolactin-induced adenomyosis in mice. Acta Anat 1983;116:46-54.
54. Sakamoto S, Mori T, Singtripop T. Increase of DNA synthesis in uterine adenomyosis in mice with ectopic pituitary isograft. Acta Anat 1992;145:162-6.
55. Mori S, Fuji M, Kudo R. Expression of the small molecular weight matrix metalloproteinase in adenomyosis of the mouse uterus. Acta Obstet Gynecol Scand 1996;48:386-92.
56. Matsuda M, Sasabe H, Adachi Y, Suzuki T, Mori T. Increased invasion activity of endometrial stromal cells and elevated expression of matrix metalloproteinase messenger RNA in the uterine tissues of mice with experimentally induced adenomyosis. Am J Obstet Gynecol 2001;185: 1374-80.
57. Kida H. Histological analysis of spontaneous adenomyosis-like changes in recombinant inbred mouse uterus (SMXZ mouse): a novel animal model for adenomyosis. Acta Obstet Gynecol Scand 1994;46:323-30.
58. Goumenou AG, Arvanitis DA, Matalliotakis IM, Koumantakis EE, Spandidos DA. Loss of heterozygosity in adenomyosis on hMSH2, hMSLH1, p16Ink4 and GALT loci. Int J Mol Med 2000;6:667-71.
59. Goumenou A, Panayiotides I, Matalliotakis I, Vlachonikolis I, Tzardi M, Koumantakis E. Bcl-2 and Bax expression in human endometriotic and adenomyotic tissues. Eur J Obstet Gynecol Reprod Biol 2001;99:256-60.
60. Donnez J, Nisolle M, Gillerot S, Bassil S, Casans-Roux F. Rectovaginal septum adenomyotic nodules: a series of 500 cases. Br J Obstet Gynecol 1997;104:1014-8.
61. Donnez J, Nisolle M, Squifflet J. Ureteral endometriosis: a complication of rectovaginal endometriotic (adenomyotic) nodules. Fertil Steril 2002;77:32-7.
62. Nisolle M, Donnez J. Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of the rectovaginal septum are three different entities. Fertil Steril 1997;68:585-96.
63. Molitor JJ. Adenomyosis: a clinical and pathologic appraisal. Am J Obstet Gynecol 1971; 110:275-8.
64. Langlois PL. The size of the normal uterus. J Reprod Med 1970;28:1008-11.
65. Azziz R. Adenomyosis: current perspectives. Obstet Gynecol Clin North Am 1989;16:221-35.
66. Hendrickson MR, Kempson RL. Surgical pathology of the uterine corpus. Major Probe Pathol 1979;12:1-580.
67. Sandberg EG, Cohn F. Adenomyosis in the gravid uterus at term. Am J Obstet Gynecol 1962;84:1457-65.
68. Haber G, Ferenczy A. Electrosurgical solutions to gynecological problems. Contemp Obstet Gynecol 1993;1:25-36.
69. Mathur BBI, Shah RS, Bhende YM. Adenomyosis uteri: a pathologic study of 290 cases. Am J Obstet Gynecol 1962;84:1820-9.
70. Azziz R. Adenomyosis in pregnancy: a review. J Reprod Med 1986;31:224-7.
71. Colman HI, Rosenthal AH. Carcinoma developing in areas of adenomyosis. Obstet Gynecol 1959;14:341-8.
72. Winkelman J, Robinson R. Adenocarcinoma of endometrium involving adenomyosis. Cancer 1996;19:901-8.
73. Benson RC, Sneeden VD. Adenomyosis: a reappraisal of symptomatology. Am J Obstet Gynecol 1958;76:1044-61.
74. Nishida M. Relationship between the onset of dysmenorrhea and histologic findings in adenomyosis. Am J Obstet Gynecol 1991;165:229-31.
75. Propst AM, Quade BJ, Gargiulo AR, Nowak RA, Stewart EA. Adenomyosis demonstrates increased expression of the basic fibroblast growth factor receptor/ligand system compared with autologous endometrium. Menopause 2001;8:368-71.
76. Nikkanen V, Punnonen R. Clinical significance of adenomyosis. Ann Chir Gynaecol 1980;69: 278-80.
77. Kilkku P, Erkolla R, Gronroos M. Nonspecificity of symptoms related to adenomyosis: a prospective comparative survey. Acta Obstet Gynecol Scand 1984;62:229-31.
78. Martinez-Mir I, Estan L, Morales-Olivas FJ. Studies of the spontaneous motility and the effect of histamine on isolated myometrial strips of the non-pregnant human uterus: the influence of various uterine abnormalities. Am J Obstet Gynecol 1990;163:189-95.
79. Israel SL, Woutersz TB. Adenomyosis: a neglected diagnosis. Obstet Gynecol 1959;14:168-71.
80. Owolabi TO, Strickler RC. Adenomyosis: a neglected diagnosis. Obstet Gynecol 1977; 50:424-7.
81. Thompson JR, Davion RJ. Adenomyosis of the uterus: an enigma. J Natl Med Assoc 1986;78: 305-9.
82. Dougherty CM, Anderson MR. Endometriosis and adenomyosis. Am J Obstet Gynecol 1964; 89:23-4.
83. Nikkanen V, Punnonen R. Clinical significance of adenomyosis. Ann Chir Gvnaecol 1980; 68:278-80.
84. Honore LH, Gumming DC, Dunlop DU. Uterine adenomyoma associated with infertility: a report of three cases. J Reprod Med 1988;33:331-5.
85. Hirata JD, Moghissi KS, Ginsburg KA. Pregnancy after medical therapy of adenomyosis with a gonadotropin-releasing hormone agonist. Fertil Steril 1993;59:444-5.
86. Nelson JR, Corson SL. Long-term management of adenomyosis with a gonadotropin releasing hormone agonist: a case report. Fertil Steril 1993;59:441-3.
87. Silva PD, Perkins RE, Schauberger CW. Live birth after treatment of severe adenomyosis with a gonadotropin-releasing hormone agonist. Fertil Steril 1994;61:171-2.
88. Ota R, Maki M, Shidara Y. Effects of danazol at the immunological level in patients with adenomyosis, with special reference to autoantibodies: a multi-center cooperative study. Am J Obstet Gynecol 1992;167:481-6.
89. McCarthy S. Magnetic resonance imaging in the evaluation of infertile women. Magn Reson Imaging 1990;6:239-49.
90. Woodward PJ, Wagner BJ, Fariey TE. MR imaging in the evaluation of female infertility. Radiographics 1993;13:293-310.
91. de Souza NM, Brosens JJ, Schwieso JE. The potential value of magnetic resonance imaging in infertility. Clin Radiol 1995;50:75-9.
92. Daya S. Endometriosis and spontaneous abortion. In: Coutinho EM, Spinola P, de Moura LH, editors. Progress in the management of endometriosis. New York: Parthenon; 1994. p. 61-8.
93. Olive DL, Franklin RR, Gratkins LV. The association between endometriosis and spontaneous abortion: a retrospective clinical study. J Reprod Med 1982;27:333-8.
94. Kano T, Furudono M, Nabetani H. The incidence of endometriosis and adenomyosis in patients with habitual abortion in relation to immunological abnormalities. Jpn J Fertil Steril 1997;42: 113-8.
95. Parazzini E, Vercellini P, Panazza S. Risk factors for adenomyosis. Hum Reprod 1997; 12:1275-9.
96. Tseng L, Zhang J, Pereskni T, Yu C. Cyclic expression of endothelial nitric oxide synthase mRNA in the epithelial glands of human endometrium. J Soc Gynecol Invest 1996;3:33-8.
97. Telfer JJF, Irvine GA, Kohnen G. Expression of endothelial and inducible nitric oxide synthase in non-pregnant and decidualised human endometrium. Mol Hum Reprod 1997;3:69-75.
98. Ota R, Igarashi S, Hatazawa J. Endothelial nitric oxide synthase in the endometrium during the menstrual cycle in patients with endometriosis and adenomyosis. Fertil Steril 1998;69: 303-8.
99. Rosselli M, Dubey RK, Immum B. Effects of nitric oxide on human spermatozoa: evidence that nitric oxide decreases sperm motility and induces sperm toxicity. Hum Reprod 1995;10: 1786-90.
100. Zini A, De Lamirande E, Gagnon C. Low levels of nitric oxide promote human sperm capacitation in vitro. J Androl 1995;16:424-31.
101. Lee QP, Juchau MR. Dysmorphogenic effects of nitric oxide (NO) and NO-synthase inhibition: studies with intra-amniotic injections of sodium nitroprusside and NG-monomethyl-L-arginine. Teratology 1994;49:452-64.
102. Haydon GB. A study of 569 cases of endometriosis. Am J Obstet Gynecol 1942;43:704-8.
103. Emge LA. The elusive adenomyosis of the uterus: its historical past and its present state of recognition. Am J Obstet Gynecol 1962;83:1541-5.
104. Hemandez E, Woodruff JD. Endometrial adenocarcinoma arising in adenomyosis. Am J Obstet Gynecol 1980;138:827-31.
105. Hall JB, Young RH, Nelson JH. The prognostic significance of adenomyosis in endometrial carcinoma. Gynecol Oncol 1984;17:32-6.
106. Gisser SD, Toker C. Endometrial stromal sarcoma and leiomyosarcoma arising in adenomyosis: a possible presentation of occult extra-genital malignancy. Mt Sinai J Med 1978;45:218-22.
107. Oda Y, Nakanishi I, Tateiwa T. Intramural müllerian adenosarcoma of the uterus with adenomyosis. Arch Pathol Lab Med 1987;108:798-802.
108. Hayata T, Kawashima Y. Clinicopathologic study of eight cases of uterine body cancers associated with endometriosis interna (uterine adenomyosis). Am J Obstet Gynecol 1987;156:663-6.
109. Lee NC, Dicker RC, Rubin GL. Confirmation of the preoperative diagnoses for hysterectomy. Am J Obstet Gynecol 1984;150:283-7.
110. Bergholt T, Eriksen L, Berendt N, Jacobsen M, Hertz JB. Prevalence and risk factors of adenomyosis at hysterectomy. Hum Reprod 2001;16:2418-21.
111. Marshak RH, Eliasoph J. The roentgen findings in adenomyosis. Radiology 1955;64:846-9.
112. Siegler AM. Hysterography and hysteroscopy in the infertile patient. J Reprod Med 1977;78:143-8.
113. Wolf DM, Spataro RF. The current state of hysterosalpingography. Radiographics 1988;8:1041-6.
114. Walsh JW, Taylor KJ, Rosenfield AT. Gray scale ultrasonography in the diagnosis of endometriosis and adenomyosis. Am J Roentgenol 1979;132:87-91.
115. Siedler D, Laing FC, Jeffrey RB, Wing VW. Uterine adenomyosis: a difficult sonographic diagnosis. J Ultrasound Med 1987;6:345-9.
116. Fedele L. Transvaginal ultrasonography in the diagnosis of diffuse adenomyosis. Fertil Steril 1992;58:94-8.
117. Ascher SM, Arnold LL, Part RH. Adenomyosis: prospective comparison of MR imaging and transvaginal sonography. Radiology 1994;190:803-6.
118. Wood C, Hurley VA, Leoni M. The value of vaginal ultrasound in the management of menorrhagia. Aust N Z J Obstet Gynaecol 1993;33:198-201.
119. Lee JKT, Gersell DJ, Balfe DM. The uterus in vitro MR: anatomic correlation of normal and abnormal specimens. Radiology 1985;157:175-7.
120. Mark AS, Hricak IT, Heinrichs LW. Adenomyosis and leiomyoma: differential diagnosis with MR imaging. Radiology 1987;163:527-30.
121. Reinhold C, Tafazoli F, Wang L. Imaging features of adenomyosis. Hum Reprod 1998;4: 337-49.
122. Togashi K, Ozasa H, Konishi I. Enlarged uterus: differentiation between adenomyosis and leiomyoma with MR imaging. Radiology 1989;71:531-4.
123. Panidis D, Vlassis G, Arvanitidou-Vajionas M, Matalliotakis I, Kalogeropoulos A. Serum levels of the oncofetal antigens CA-125, CA 19-9, and CA 15-3 in patients with endometriosis. J Endocrinol Invest 1988;11:801-5.
124. Matalliotakis I, Neonaki M, Panidis D, Goumenou A, Koumantakis E. Three-year follow-up of CA-125, CA 19-9, CA 15-3, SIL-2R, IL-6. IL-1a, TNF-a, sCD8 and s(D4) levels in a woman with severe endometriosis. Eur J Obstet Gynecol Reprod Biol 2000;93:127-9.
125. Takahashi K, Kijima S, Yoshino K. Differential diagnosis between leiomyomata uteri and adenomyosis using CA-125 as a new tumor marker of ovarian carcinoma. Nippon Sanka Fujinka Gakkai Zasshi 1985;37:591-5.
126. Kijima S, Takahashi K, Kitao M. Expression of CA-125 in adenomyosis. Gynecol Obstet Invest 1987;23:122-6.
127. Halila H, Suikkari AM, Seppala M. The effect of hysterectomy on serum CA-125 levels in patients with adenomyosis and uterine fibroids. Hum Reprod 1987;2:265-8.
128. Blum M, Sirote P. Serum cystine aminopeptidase and leucine aminopeptidase activity in women with benign and malignant uterine and ovarian rumors. Isr J Med Sci 1977;13:875-9.
129. McCausland A. Hysteroscopic myometrial biopsy: its use in diagnosing adenomyosis and its clinical application. Am J Obstet Gynecol 1992;166:1619-26.
130. Popp L, Schwiedessen J, Gaetje R. Myometrial biopsy in the diagnosis of adenomyosis uteri. Am J Obstet Gynecol 1993;169:546-9.
131. Brosens J, Barker F. The role of myometrial needle biopsies in the diagnosis of adenomyosis. Fertil Steril 1995;63:1347-9.
132. Nagasawa H, Mori T. Stimulation of mammary tumorigenesis and suppression of uterine adenomyosis by temporary inhibition of pituitary prolactin secretion during youth in mice. Proc Soc Exp Biol Med 1982;171:164-8.
133. Nagasawa H, Noguchi Y, Mori T. Suppression of normal and preneoplastic mammary growth and uterine adenomyosis with reduced growth hormone level in SHN mice given monosodium glutamate neonatally. Eur J Cancer Clin Oncol 1985;21:1547-9.
134. Nagasawa H, Ishida M, Mori T. Effects of treatment with prolactin or progesterone on the coincidence of mammary tumors and uterine adenomyosis in young SHX mice. Lab Anim Sci 1987;37:200-4.
135. Nagasawa H, Aoki M, Mori T. Stimulation of mammary tumorigenesis and inhibition of uterine adenomyosis by suppressed progestone effects in SHN mice. Anticancer Res 1989;9:827-31.
136. Falk R, Mullin B. Exacerbation of adenomyosis symptomatology by estrogen-progestin therapy: a case report and histopathological observations. Int J Fertil 1989;34:386-9.
137. Lauersen NH, Wilson KH, Birnbaum S. Danazol: an antigonadotrophic agent in the treatment of pelvic endometriosis. Am J Obstet Gynecol 1975;123:742-4.
138. Ingerslev M. Danazol: an antigonadotrophic agent in the treatment of recurrent pelvic and intestinal endometriosis. Acta Obstet Gynecol Scand 1977;56:343-6.
139. Singtripop T, Mori T, Sakamoto S, Sassa S, Park MK, Kawashima S. Suppression of the development of uterine adenomyosis by danazol treatment in mice. Life Sci 1992;51:1119-25.
140. Tamaoka Y, Orikasa H, Sakakura K, Kamei K, Nagatani M, Ezawa S. Direct effect of danazol on endometrial hyperplasia in adenomyotic women: treatment with danazol containing intrauterine device. Hum Cell 2000;13:127-33.
141. Fong YF, Singh K. Medical treatment of a grossly enlarged adenomyotic uterus with the levonorgestrel-releasing intrauterine system. Contraception 1999;60:173-7.
142. Huang FJ, Kung FT, Chang SY, Hsu TY. Effects of short-course buserelin therapy on adenomyosis: a report of two cases. J Reprod Med 1999;44:741-3.
143. Wood C. Surgical and medical treatment of adenomyosis. Hum Reprod Update 1998;4:323-5.
144. McCausland V, McCausland A. The response of adenomyosis to endometrial ablation/resection. Hum Reprod Update 1998;4:350-3.
145. Mori T, Yamasaki S, Masui F, Matsuda M, Sasabe H, Zhou YF. Suppression of the development of experimentally induced uterine adenomyosis by a novel matrix metalloproteinase inhibitor, ONO-4817, in mice. Exp Biol Med 2001;226:429-33.